Royalty Pharma plc (RPRX) Insider Trading -- Recent Executive & Director Transactions

15 insiders reported 123 Form 4 transactions for Royalty Pharma plc (RPRX) over the past 18 months (most recent 2026-07-02). Recent activity: Hite Christopher (EVP & Chairman, Partnering) Sell 97,446 shares, Urist Marshall (EVP, Research & Investments) Sell 9,099 shares, Hite Christopher (EVP & Chairman, Partnering) Sell 2,554 shares, Hite Christopher (EVP & Chairman, Partnering) Sell 29,400 shares, Hite Christopher (EVP & Chairman, Partnering) Sell 600 shares. Source: SEC Form 4.

DateInsiderTitleTypeSharesValue
2026-07-02Hite ChristopherEVP & Chairman, PartneringSell97,446$5.5M
2026-07-02Urist MarshallEVP, Research & InvestmentsSell9,099$508,454
2026-07-02Hite ChristopherEVP & Chairman, PartneringSell2,554$145,841
2026-07-02Hite ChristopherEVP & Chairman, PartneringSell29,400$1.7M
2026-07-02Hite ChristopherEVP & Chairman, PartneringSell600$34,254
2026-06-30Bassler Bonnie LDirectorBuy689$37,481
2026-06-25Hite ChristopherEVP & Chairman, PartneringSell32,408$1.8M
2026-06-25Urist MarshallEVP, Research & InvestmentsSell9,098$502,067
2026-06-25Hite ChristopherEVP & Chairman, PartneringSell117,592$6.4M
2026-06-08Bassler Bonnie LDirectorBuy4,545$0
2026-06-08LOVE TED WDirectorBuy4,545$0
2026-06-08HODGSON DAVID CDirectorBuy4,545$0
2026-06-08WEATHERMAN ELIZABETH HDirectorBuy4,545$0
2026-06-08Coric VladDirectorBuy4,545$0
2026-06-08Ho CaroleDirectorBuy4,545$0
2026-06-08Engelbert Catherine M.DirectorBuy4,545$0
2026-06-08Norden GregoryDirectorBuy4,545$0
2026-05-21Urist MarshallEVP, Research & InvestmentsSell13,684$721,838
2026-05-15Norden GregoryDirectorSell3,045$161,385
2026-05-15Urist MarshallEVP, Research & InvestmentsSell13,684$726,137
2026-05-08Legorreta Pablo G.CEO, Chairman of the BoardBuy143,821$0
2026-05-08Hite ChristopherEVP & Vice ChairmanBuy24,263$0
2026-05-08Coyne Terrance P.EVP & CFOBuy24,263$0
2026-05-08Urist MarshallEVP, Research & InvestmentsBuy18,197$0
2026-04-30Coyne Terrance P.EVP & CFOSell32,916$1.6M

Source: SEC Form 4 filings · as of 2026-07-02